DNLI Operating Expenses

Denali Therapeutics Inc · Operating Expenses

DNLI logo

DNLI Operating Expenses

Latest reported$540.50M
DNLI TTM Operating Expenses ($87.52M → $540.50M)
High-resolution chart · PNG

DNLI operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Denali Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
540,497,000
541,408,000
552,476,000
547,823,000
533,576,000
515,206,000
487,341,000
490,067,000
481,942,000
488,989,000
527,230,000
510,285,000
506,268,000
496,524,000
449,207,000
423,215,000
403,048,000
373,908,000
344,412,000
327,514,000
306,145,000
288,513,000
272,941,000
262,634,000
256,884,000
256,720,000
239,862,000
228,386,000
203,786,000
195,856,000
175,532,000
148,118,000
131,247,000
94,785,000
90,140,000
86,466,000
95,110,000
90,904,499
87,522,998
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.